KYMR

Kymera Therapeutics Inc

$114.67

5.35 (4.89%) Today

— up— down

Market Cap

$8.99B+162.8%

Revenue (TTM)

$43.42M-12.6%

Net Income (TTM)

$-293,651,748

$-293,651,748

EPS (TTM)

-3.57

-3.57

Shares Out

82.26M

82.26M

Open

$110.39

$110.39

Previous Close

$109.32

$109.32

Day Range

$109.67 – $118.48

$109.67 – $118.48

52-Week Range

$36.65 – $130.05

$36.65 – $130.05

Beta

1.87

1.87

Volume

1.12M

1.12M

Avg Volume

752.51K

752.51K

Analyst Rating

Buy

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

NASDAQ NMS - GLOBAL MARKET

About KYMR

Related

News

B of A Securities Maintains Buy on Kymera Therapeutics, Raises Price Target to $125

Benzinga · 12h ago

Truist Securities Maintains Buy on Kymera Therapeutics, Raises Price Target to $136

Benzinga · 1d ago

B. Riley Securities Maintains Buy on Kymera Therapeutics, Raises Price Target to $155

Benzinga · 1d ago

Canaccord Genuity Maintains Buy on Kymera Therapeutics, Raises Price Target to $129

Benzinga · 4d ago

Kymera Therapeutics Stock Climbs On Accelerated Timeline For Lead Atopic Dermatitis Program

Benzinga · 5d ago